Expansion of functional personalized cells with specific transgene combinations.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Lipps, ChristophKlein, Franziska
Wahlicht, Tom
Seiffert, Virginia
Butueva, Milada
Zauers, Jeannette
Truschel, Theresa
Luckner, Martin
Köster, Mario
MacLeod, Roderick
Pezoldt, Jörn
Hühn, Jochen
Yuan, Qinggong
Müller, Peter Paul
Kempf, Henning
Zweigerdt, Robert
Dittrich-Breiholz, Oliver
Pufe, Thomas
Beckmann, Rainer
Drescher, Wolf
Riancho, Jose
Sañudo, Carolina
Korff, Thomas
Opalka, Bertram
Rebmann, Vera
Göthert, Joachim R
Alves, Paula M
Ott, Michael
Schucht, Roland
Hauser, Hansjörg
Wirth, Dagmar
May, Tobias
Issue Date
2018-03-08
Metadata
Show full item recordAbstract
Fundamental research and drug development for personalized medicine necessitates cell cultures from defined genetic backgrounds. However, providing sufficient numbers of authentic cells from individuals poses a challenge. Here, we present a new strategy for rapid cell expansion that overcomes current limitations. Using a small gene library, we expanded primary cells from different tissues, donors, and species. Cell-type-specific regimens that allow the reproducible creation of cell lines were identified. In depth characterization of a series of endothelial and hepatocytic cell lines confirmed phenotypic stability and functionality. Applying this technology enables rapid, efficient, and reliable production of unlimited numbers of personalized cells. As such, these cell systems support mechanistic studies, epidemiological research, and tailored drug development.Citation
Nat Commun. 2018;9(1):994. Published 2018 Mar 8. doi:10.1038/s41467-018-03408-4.Affiliation
HZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.Publisher
Springer NatureJournal
Nature communicationsPubMed ID
29520052Type
ArticleOther
Language
enEISSN
2041-1723ae974a485f413a2113503eed53cd6c53
10.1038/s41467-018-03408-4
Scopus Count
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
Related articles
- Mixed hematopoietic molecular chimerism results in permanent transgene expression from retrovirally transduced hepatocytes in mice.
- Authors: Pichard V, Bellodi-Privato M, Gournay J, Ferry N
- Issue date: 2006 Apr
- Optimal promoter usage for lentiviral vector-mediated transduction of cultured central nervous system cells.
- Authors: Li M, Husic N, Lin Y, Christensen H, Malik I, McIver S, LaPash Daniels CM, Harris DA, Kotzbauer PT, Goldberg MP, Snider BJ
- Issue date: 2010 May 30
- Epidermal growth factor improves lentivirus vector gene transfer into primary mouse hepatocytes.
- Authors: Rothe M, Rittelmeyer I, Iken M, Rüdrich U, Schambach A, Glage S, Manns MP, Baum C, Bock M, Ott M, Modlich U
- Issue date: 2012 Apr
- Promoter interference mediated by the U3 region in early-generation HIV-1-derived lentivirus vectors can influence detection of transgene expression in a cell-type and species-specific manner.
- Authors: Ginn SL, Fleming J, Rowe PB, Alexander IE
- Issue date: 2003 Aug 10
- A highly efficient, stable, and rapid approach for ex vivo human liver gene therapy via a FLAP lentiviral vector.
- Authors: Giannini C, Morosan S, Tralhao JG, Guidotti JE, Battaglia S, Mollier K, Hannoun L, Kremsdorf D, Gilgenkrantz H, Charneau P
- Issue date: 2003 Jul